Back
Nuveen Credit Strategies Income Fund Vs. LeMaitre Vascular, Inc. Industry Stock Comparison
Sell
37
JQC
Nuveen Credit Strategies Income Fund
Last Price:
$4.73
Seasonality Move:
0.81%
Buy
60
LMAT
LeMaitre Vascular, Inc.
Last Price:
$108.31
Seasonality Move:
9.89%
Sell
37
Nuveen Credit Strategies Income Fund (JQC)
is a Sell
Is Nuveen Credit Strategies Income Fund a Buy, Sell or Hold?
-
The current Nuveen Credit Strategies Income Fund [JQC] share price is $4.73. The Score for JQC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
JQC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
LeMaitre Vascular, Inc. (LMAT)
is a Buy
Is LeMaitre Vascular, Inc. a Buy, Sell or Hold?
-
The current LeMaitre Vascular, Inc. [LMAT] share price is $108.49. The Score for LMAT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
LMAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JQC Stock Price Chart
What is Nuveen Credit Strategies Income Fund's stock price today?
-
The Nuveen Credit Strategies Income Fund share price today is $4.73The current trend is relatively stagnant and JQC is experiencing selling pressure, which indicates risk of future bearish movement.
LMAT Stock Price Chart
What is LeMaitre Vascular, Inc.'s stock price today?
-
The LeMaitre Vascular, Inc. share price today is $108.49The current trend is moderately bullish and LMAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
JQC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.25 | Buy |
| Relative Strength Index (14 RSI): | 43.15 | Sell |
| Chaikin Money Flow: | -459407 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.73 - 4.87) | Sell |
| Bollinger Bands (100): | (4.86 - 5.12) | Sell |
LMAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.47 | Buy |
| Relative Strength Index (14 RSI): | 56.35 | Buy |
| Chaikin Money Flow: | 74546 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (106.9 - 110.22) | Sell |
| Bollinger Bands (100): | (81.37 - 102.13) | Buy |
JQC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.77 | Sell |
| 20-day SMA: | 4.78 | Sell |
| 50-day SMA: | 4.92 | Sell |
| 200-day SMA: | 5.18 | Sell |
| 8-day EMA: | 4.54 | Buy |
| 20-day EMA: | 3.34 | Buy |
| 50-day EMA: | 1.82 | Buy |
| 200-day EMA: | 0.54 | Buy |
LMAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.91 | Sell |
| 20-day SMA: | 108.9 | Sell |
| 50-day SMA: | 98.64 | Buy |
| 200-day SMA: | 90.01 | Buy |
| 8-day EMA: | 108.6 | Sell |
| 20-day EMA: | 107.27 | Buy |
| 50-day EMA: | 101.1 | Buy |
| 200-day EMA: | 91.91 | Buy |
Nuveen Credit Strategies Income Fund Earnings Growth & JQC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
LeMaitre Vascular, Inc. Earnings Growth & LMAT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.01 per share, an increase this year of $0.48 per share, and an increase next year of $0.28 per share.
Nuveen Credit Strategies Income Fund Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
LeMaitre Vascular, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||